Last updated at 18 Jun 2025 06:22 AM
Director
DIN: 09793585
Ketankumar Kanubhai Patel is currently associated with 3 companies in various capacities such as Partner, Designated Partner and Director. They serve as a Director at VEDANT PHARMACY LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09793585.Ketankumar Kanubhai Patel has previously been associated with 1 company in roles such as Additional Director.Ketankumar Kanubhai Patel is currently involved in 3 different roles. Their most recent position is with KRISH MEDICARE PRIVATE LIMITED as a Director. The first company Ketankumar Kanubhai Patel was appointed to as a director was VEDANT PHARMACY LLP. Ketankumar Kanubhai Patel is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ketankumar Kanubhai Patel is currently associated with 3 companies in various capacities such as Partner, Designated Partner and Director. They serve as a Director at VEDANT PHARMACY LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09793585.Ketankumar Kanubhai Patel has previously been associated with 1 company in roles such as Additional Director.Ketankumar Kanubhai Patel is currently involved in 3 different roles. Their most recent position is with KRISH MEDICARE PRIVATE LIMITED as a Director. The first company Ketankumar Kanubhai Patel was appointed to as a director was VEDANT PHARMACY LLP. Ketankumar Kanubhai Patel is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (2)
Past Companies (1)
1y 2m 7 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| KRISH MEDICARE PRIVATE LIMITED | Director | 30-Sep-2023 |